Champions Oncology (CSBR) Total Liabilities (2011 - 2026)

Champions Oncology's Total Liabilities history runs 16 years deep, the most recent figure standing at $24.1 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 4.33% year-over-year to $24.1 million; the TTM figure through Jan 2026 stood at $24.1 million (down 4.33% YoY), while the FY2025 annual figure was $28.6 million, up 1.92% from the prior year.
• Total Liabilities was $24.1 million for Q1 2026 at Champions Oncology, down from $25.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $29.7 million in Q2 2023 to a low of $24.1 million in Q1 2026.
• Historically, Total Liabilities has averaged $26.8 million across 5 years, with a median of $27.0 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities surged 41.77% in 2022, then fell 12.91% in 2024.
• A 5-year view of Total Liabilities shows it stood at $27.2 million in 2022, then rose by 3.71% to $28.2 million in 2023, then slipped by 12.91% to $24.6 million in 2024, then rose by 5.59% to $25.9 million in 2025, then decreased by 7.18% to $24.1 million in 2026.
• The last three Total Liabilities figures came in at $24.1 million (Q1 2026), $25.9 million (Q4 2025), and $27.0 million (Q3 2025), per Business Quant data.